REAL-TIME GLOBAL RESEARCH
Risk Reward Update
Research evidence excerpt
Risk Reward Update
UpdateM
Risk Reward – Dr. Sulaiman Al Habib Medical Group (4013.SE)
KEY EARNINGS INPUTS
Drivers Dec 2025 Dec 2026e Dec 2027e Dec 2028e
Total beds 3,457 3,457 3,457 3,597
Utilisation rate (%) 60.0 65.0 75.0 77.9
Pharmacies revenues 2,856 3,125 3,574 3,860
Solutions/others revenues 251 297 364 393
INVESTMENT DRIVERS RISKS TO PT/RATING MS ESTIMATES VS. CONSENSUS
Population growth in KSA (+16% from 2025- RISKS TO UPSIDE FY Dec 2026e
2035, at a CAGR of 1.5%) Greater market expansion for the premium
Expansion of private health insurance coverage insurance class in Riyadh Sales / 14,894
Shortage of hospital beds in KSA Agreement reached with Insurance players on Revenue 14,424 16,054
Capacity expansion pipeline: 4 hospitals and 590 price increases (SAR, mn) 15,466
beds by 2030 Accelerated rollout of private health insurance
coverage across KSA
(3,618)
GLOBAL REVENUE EXPOSURE RISKS TO DOWNSIDE EBITDA (4,032) 4,095
(SAR, mn)
Intensified competition in home markets: e.g. 2,843
premium insurance class and/or Riyadh
100% MEA Faster implementation of DRG payments
7.13
system EPS
6.22 8.56
Execution risks for pipeline projects (SAR)
7.36
Source: Morgan Stanley Research Estimate
View explanation of regional hierarchies here OWNERSHIP POSITIONING
4.99
DPS Inst. Owners, % Active 42.6% 4.36 5.99
MS ALPHA MODELS (SAR)
HF Sector Long/Short Ratio 2.6x 5.16
4/5 3 Month HF Sector Net Exposure 13.1%
MOST Horizon Mean Morgan Stanley Estimates
Refinitiv; MSPB Content. Includes certain hedge fund Source: Refinitiv, Morgan Stanley Research
Source: Refinitiv, FactSet, Morgan Stanley Research; 1 is exposures held with MSPB. Information may be
the highest favored Quintile and 5 is the least favored inconsistent with or may not reflect broader market
Quintile trends.
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer